Recombinant Fv-Hsp70 Protein Mediates Neuroprotection after Focal Cerebral Ischemia in Rats

Xinhua Zhan,Bradley P. Ander,Isaac H. Liao,James E. Hansen,Chester Kim,Douglas Clements,Richard H. Weisbart,Robert N. Nishimura,Frank R. Sharp
DOI: https://doi.org/10.1161/strokeaha.109.572537
IF: 10.17
2010-01-01
Stroke
Abstract:Background and Purpose—This study investigated the effects of intravenous recombinant Fv-Hsp70 protein on infarction volume and behavior after experimental ischemic stroke.Methods—Focal cerebral ischemia was produced by occluding the middle cerebral artery using the intraluminal suture technique. Rats subjected to 2 hours of focal ischemia were allowed to survive 24 hours. At 2¼ hours and 3 hours after onset of ischemia, Fv-Hsp70 recombinant protein (0.5 mg/kg) or saline was injected through the tail vein. Sensorimotor function and infarction volume were assessed at 24 hours after ischemia.Results—Administration of Fv-Hsp70 after focal cerebral ischemia significantly decreased infarct volume by 68% and significantly improved sensorimotor function compared with the saline-treated control group. Western blots showed Fv-Hsp70 in ischemic but not in control brain; and Fv-Hsp70 suppressed endogenous Hsp70.Conclusion—Fv-Hsp70 protected the ischemic brain in this experimental stroke model.
What problem does this paper attempt to address?